AVM is a development-stage biotech company advancing the research, development and commercialization of game-changing stem cell technologies for high unmet medical needs in regenerative medicine, cancer treatment recovery, safer iPS cell culturing and treatment, and fully human biologics, including patient-specific biologics for personalized medicine (“Boutique Biologics™”) in orphan diseases.

Biotechnology

AVM Biotech

AVM Biotech's headquarters in Seattle, WA, United States

Theresa A. Deisher, Ph.D.

Todd Bertsch

Siuliana Limasi

Terry Kopp

Jena Dalpez

Gordon Roble, D.V.M.

Frank Buttgereit, M.D.

Edward Loniewski, D.O.

Gustavo Mahler, Ph.D.

Gianpietro Dotti

William Matsui, M.D.

Description

People (2)

Theresa A. Deisher, Ph.D.

Gordon Roble, D.V.M.